Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 257

1.

A phase II study of preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor: a report from the Children's Oncology Group (CCG 9931).

Allen J, Donahue B, Mehta M, Miller DC, Rorke LB, Jakacki R, Robertson P, Sposto R, Holmes E, Vezina G, Muraszko K, Puccetti D, Prados M, Chan KW.

Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1006-11. doi: 10.1016/j.ijrobp.2008.09.019. Epub 2009 Apr 7.

2.

Patterns of treatment failure in infants with primitive neuroectodermal tumors who were treated on CCG-921: a phase III combined modality study.

Hong TS, Mehta MP, Boyett JM, Donahue B, Rorke LB, Zeltzer PM.

Pediatr Blood Cancer. 2005 Oct 15;45(5):676-82.

PMID:
16007595
3.

INI1 protein expression distinguishes atypical teratoid/rhabdoid tumor from choroid plexus carcinoma.

Judkins AR, Burger PC, Hamilton RL, Kleinschmidt-DeMasters B, Perry A, Pomeroy SL, Rosenblum MK, Yachnis AT, Zhou H, Rorke LB, Biegel JA.

J Neuropathol Exp Neurol. 2005 May;64(5):391-7.

PMID:
15892296
4.

Recurrent central nervous system medulloepithelioma: response and outcome following marrow-ablative chemotherapy with stem cell rescue.

Norris LS, Snodgrass S, Miller DC, Wisoff J, Garvin J, Rorke LB, Finlay JL.

J Pediatr Hematol Oncol. 2005 May;27(5):264-6.

PMID:
15891561
5.

Lipoma of the tuber cinereum.

Chu AY, Rorke LB, Hood IC.

Arch Pathol Lab Med. 2005 May;129(5):708-9. No abstract available.

PMID:
15859652
6.

Losses of chromosomes 1p and 19q are rare in pediatric oligodendrogliomas.

Kreiger PA, Okada Y, Simon S, Rorke LB, Louis DN, Golden JA.

Acta Neuropathol. 2005 Apr;109(4):387-92. Epub 2005 Mar 1.

PMID:
15739101
7.

Patterns of failure in supratentorial primitive neuroectodermal tumors treated in Children's Cancer Group Study 921, a phase III combined modality study.

Hong TS, Mehta MP, Boyett JM, Donahue B, Rorke LB, Yao MS, Zeltzer PM.

Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):204-13.

PMID:
15337557
8.

Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry.

Hilden JM, Meerbaum S, Burger P, Finlay J, Janss A, Scheithauer BW, Walter AW, Rorke LB, Biegel JA.

J Clin Oncol. 2004 Jul 15;22(14):2877-84.

PMID:
15254056
9.

Double immunolabeling of central nervous system atypical teratoid/rhabdoid tumors.

Bouffard JP, Sandberg GD, Golden JA, Rorke LB.

Mod Pathol. 2004 Jun;17(6):679-83.

10.

Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms.

Judkins AR, Mauger J, Ht A, Rorke LB, Biegel JA.

Am J Surg Pathol. 2004 May;28(5):644-50.

PMID:
15105654
11.

Technical communication: rationale and technique for examination of nervous system in suspected infant victims of abuse.

Judkins AR, Hood IG, Mirchandani HG, Rorke LB.

Am J Forensic Med Pathol. 2004 Mar;25(1):29-32.

PMID:
15075685
12.

Prognostic limitations of the Daumas-Duport grading scheme in infratentorial neuroglial tumors in children.

Gilles FH, Tavaré CJ, Leviton A, Hedley-Whyte ET, Sotrel A, Adelman L, Davis RL, Rorke LB; Childhood Brain Tumor Consortium.

Pediatr Dev Pathol. 2004 Mar-Apr;7(2):138-47. Epub 2004 Mar 4.

PMID:
14994132
13.

Surgery with or without radiation therapy in the management of craniopharyngiomas in children and young adults.

Stripp DC, Maity A, Janss AJ, Belasco JB, Tochner ZA, Goldwein JW, Moshang T, Rorke LB, Phillips PC, Sutton LN, Shu HK.

Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):714-20.

PMID:
14967425
14.

Loss of caspase-8 protein expression correlates with unfavorable survival outcome in childhood medulloblastoma.

Pingoud-Meier C, Lang D, Janss AJ, Rorke LB, Phillips PC, Shalaby T, Grotzer MA.

Clin Cancer Res. 2003 Dec 15;9(17):6401-9.

15.

In vivo pyruvate detected by MR spectroscopy in neonatal pyruvate dehydrogenase deficiency.

Zand DJ, Simon EM, Pulitzer SB, Wang DJ, Wang ZJ, Rorke LB, Palmieri M, Berry GT.

AJNR Am J Neuroradiol. 2003 Aug;24(7):1471-4.

16.

Expression of alpha-, beta-, and gamma-synuclein in glial tumors and medulloblastomas.

Fung KM, Rorke LB, Giasson B, Lee VM, Trojanowski JQ.

Acta Neuropathol. 2003 Aug;106(2):167-75. Epub 2003 May 28.

PMID:
12783249
17.

Correction of hindbrain herniation and anatomy of the vermis after in utero repair of myelomeningocele in sheep.

Bouchard S, Davey MG, Rintoul NE, Walsh DS, Rorke LB, Adzick NS.

J Pediatr Surg. 2003 Mar;38(3):451-8; discussion 451-8.

PMID:
12632366
18.

Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors.

Biegel JA, Tan L, Zhang F, Wainwright L, Russo P, Rorke LB.

Clin Cancer Res. 2002 Nov;8(11):3461-7.

19.

Clinical and survival covariates of eight classes of childhood supratentorial neuroglial tumors.

Gilles FH, Leviton A, Tavaré CJ, Adelman L, Rorke LB, Sobel EL, Hedley-Whyte ET, Davis RL.

Cancer. 2002 Sep 15;95(6):1302-10.

20.
21.

Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop.

Packer RJ, Biegel JA, Blaney S, Finlay J, Geyer JR, Heideman R, Hilden J, Janss AJ, Kun L, Vezina G, Rorke LB, Smith M.

J Pediatr Hematol Oncol. 2002 Jun-Jul;24(5):337-42.

PMID:
12142780
22.

Orbital neural-glial hamartoma associated with a congenital tonic pupil.

Goldstein SM, Liu GT, Edmond JC, Katowitz JA, Rorke LB.

J AAPOS. 2002 Feb;6(1):54-5.

PMID:
11907481
23.

The WHO classification of tumors of the nervous system.

Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK.

J Neuropathol Exp Neurol. 2002 Mar;61(3):215-25; discussion 226-9. Review.

PMID:
11895036
24.

Angiogenic profile of childhood primitive neuroectodermal brain tumours/medulloblastomas.

Huber H, Eggert A, Janss AJ, Wiewrodt R, Zhao H, Sutton LN, Rorke LB, Phillips PC, Grotzer MA.

Eur J Cancer. 2001 Nov;37(16):2064-72.

PMID:
11597385
25.

Medulloblastoma: clinical and biologic aspects.

Packer RJ, Cogen P, Vezina G, Rorke LB.

Neuro Oncol. 1999 Jul;1(3):232-50. doi: 10.1093/neuonc/1.3.232. Review.

26.

MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma.

Grotzer MA, Hogarty MD, Janss AJ, Liu X, Zhao H, Eggert A, Sutton LN, Rorke LB, Brodeur GM, Phillips PC.

Clin Cancer Res. 2001 Aug;7(8):2425-33.

27.

Prognostic significance of Ki-67 (MIB-1) proliferation index in childhood primitive neuroectodermal tumors of the central nervous system.

Grotzer MA, Geoerger B, Janss AJ, Zhao H, Rorke LB, Phillips PC.

Med Pediatr Oncol. 2001 Feb;36(2):268-73.

PMID:
11452934
28.

High microvessel density in primitive neuroectodermal brain tumors of childhood.

Grotzer MA, Wiewrodt R, Janss AJ, Zhao H, Cnaan A, Sutton LN, Rorke LB, Phillips PC.

Neuropediatrics. 2001 Apr;32(2):75-9.

PMID:
11414647
29.

Abundance of apoptotic neoplastic cells in diagnostic biopsy samples is not a prognostic factor in childhood primitive neuroectodermal tumors of the central nervous system.

Grotzer MA, Janss AJ, Fung KM, Sutton LN, Zhao H, Trojanowski JQ, Rorke LB, Phillips PC.

J Pediatr Hematol Oncol. 2001 Jan;23(1):25-9.

PMID:
11196266
30.

The future of neuropathology in childhood.

Rorke LB.

Childs Nerv Syst. 2000 Nov;16(10-11):805-8. Review.

PMID:
11151734
31.

Radical excision of intramedullary spinal cord tumors: surgical morbidity and long-term follow-up evaluation in 164 children and young adults.

Constantini S, Miller DC, Allen JC, Rorke LB, Freed D, Epstein FJ.

J Neurosurg. 2000 Oct;93(2 Suppl):183-93.

PMID:
11012047
32.

Mutations of the INI1 rhabdoid tumor suppressor gene in medulloblastomas and primitive neuroectodermal tumors of the central nervous system.

Biegel JA, Fogelgren B, Zhou JY, James CD, Janss AJ, Allen JC, Zagzag D, Raffel C, Rorke LB.

Clin Cancer Res. 2000 Jul;6(7):2759-63.

33.

Germline INI1 mutation in a patient with a central nervous system atypical teratoid tumor and renal rhabdoid tumor.

Biegel JA, Fogelgren B, Wainwright LM, Zhou JY, Bevan H, Rorke LB.

Genes Chromosomes Cancer. 2000 May;28(1):31-7.

PMID:
10738300
34.

Limitations of the World Health Organization classification of childhood supratentorial astrocytic tumors. Children Brain Tumor Consortium.

Gilles FH, Brown WD, Leviton A, Tavaré CJ, Adelman L, Rorke LB, Davis RL, Hedley-Whyte TE.

Cancer. 2000 Mar 15;88(6):1477-83.

PMID:
10717633
35.

Definitive classes of childhood supratentorial neuroglial tumors. The Childhood Brain Tumor Consortium.

Gilles FH, Leviton A, Tavaré CJ, Adelman L, Rorke LB, Sobel EL, Hedley-Whyte ET, Davis RL.

Pediatr Dev Pathol. 2000 Mar-Apr;3(2):126-39.

PMID:
10679032
36.

TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors.

Grotzer MA, Janss AJ, Fung K, Biegel JA, Sutton LN, Rorke LB, Zhao H, Cnaan A, Phillips PC, Lee VM, Trojanowski JQ.

J Clin Oncol. 2000 Mar;18(5):1027-35.

PMID:
10694553
37.

Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.

Packer RJ, Goldwein J, Nicholson HS, Vezina LG, Allen JC, Ris MD, Muraszko K, Rorke LB, Wara WM, Cohen BH, Boyett JM.

J Clin Oncol. 1999 Jul;17(7):2127-36.

PMID:
10561268
38.

Neuroimaging in child abuse: a mechanism-based approach.

Chen CY, Zimmerman RA, Rorke LB.

Neuroradiology. 1999 Oct;41(10):711-22. Review. No abstract available.

PMID:
10552019
39.

Neuropathology of Joubert syndrome.

Yachnis AT, Rorke LB.

J Child Neurol. 1999 Oct;14(10):655-9; discussion 669-72.

PMID:
10511338
40.

Cerebellar and brainstem development: an overview in relation to Joubert syndrome.

Yachnis AT, Rorke LB.

J Child Neurol. 1999 Sep;14(9):570-3. Review.

PMID:
10488901
41.

Ectopic brain tissue in the orbit.

Scheiner AJ, Frayer WC, Rorke LB, Heher K.

Eye (Lond). 1999 Apr;13 ( Pt 2):251-4. Review.

PMID:
10450392
42.

Accumulation of intracellular amyloid-beta peptide (A beta 1-40) in mucopolysaccharidosis brains.

Ginsberg SD, Galvin JE, Lee VM, Rorke LB, Dickson DW, Wolfe JH, Jones MZ, Trojanowski JQ.

J Neuropathol Exp Neurol. 1999 Aug;58(8):815-24.

PMID:
10446806
43.

Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.

Zeltzer PM, Boyett JM, Finlay JL, Albright AL, Rorke LB, Milstein JM, Allen JC, Stevens KR, Stanley P, Li H, Wisoff JH, Geyer JR, McGuire-Cullen P, Stehbens JA, Shurin SB, Packer RJ.

J Clin Oncol. 1999 Mar;17(3):832-45.

PMID:
10071274
44.

Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors.

Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B.

Cancer Res. 1999 Jan 1;59(1):74-9.

45.

Prognostic limitations of the Daumas-Duport grading scheme in childhood supratentorial astroglial tumors.

Brown WD, Gilles FH, Tavaré CJ, Rorke LB, Davis RL, Adelman L, Hedley-Whyte ET, Leviton A.

J Neuropathol Exp Neurol. 1998 Nov;57(11):1035-40.

PMID:
9825940
46.

Imaging studies in a unique familial dysmyelinating disorder.

Gripp KW, Zimmerman RA, Wang ZJ, Rorke LB, Duhaime AC, Schut L, Molloy PT, Tucker SH, Zackai EH, Muenke M.

AJNR Am J Neuroradiol. 1998 Aug;19(7):1368-72.

47.

Nonaccidental head injury in infants--the "shaken-baby syndrome".

Duhaime AC, Christian CW, Rorke LB, Zimmerman RA.

N Engl J Med. 1998 Jun 18;338(25):1822-9. Review. No abstract available.

PMID:
9632450
48.

MR of spinal cord ganglioglioma.

Patel U, Pinto RS, Miller DC, Handler MS, Rorke LB, Epstein FJ, Kricheff II.

AJNR Am J Neuroradiol. 1998 May;19(5):879-87.

49.

Spinal hamartomas: a distinct clinical entity.

Morris GF, Murphy K, Rorke LB, James HE.

J Neurosurg. 1998 Jun;88(6):954-7.

PMID:
9609287
50.

Prognostic value of proton MR spectroscopy of cerebral hemisphere tumors in children.

Girard N, Wang ZJ, Erbetta A, Sutton LN, Phillips PC, Rorke LB, Zimmerman RA.

Neuroradiology. 1998 Feb;40(2):121-5.

PMID:
9541923

Supplemental Content

Loading ...
Support Center